Eton Pharmaceuticals, Inc.
NASDAQ:ETON
8.62 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 21.388 | 16.305 | 14.406 | 21.295 | 12.066 | 26.735 | 13.156 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 21.388 | 16.305 | 14.406 | 21.295 | 12.066 | 26.735 | 13.156 |
Net Receivables
| 3.411 | 1.852 | 5.471 | 0.048 | 0.473 | 0 | 0 |
Inventory
| 0.911 | 0.557 | 0.55 | 1.242 | 0.38 | 0 | 0 |
Other Current Assets
| 1.129 | 1.29 | 3.177 | 2.116 | 2.09 | 0.767 | 0.136 |
Total Current Assets
| 26.839 | 20.004 | 23.604 | 24.701 | 15.009 | 27.502 | 13.292 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0.15 | 0.26 | 0.219 | 1.003 | 1.277 | 0.773 | 0.119 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 4.739 | 4.754 | 3.621 | 0.575 | 0.725 | 0 | 0 |
Goodwill and Intangible Assets
| 4.739 | 4.754 | 3.621 | 0.575 | 0.725 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.012 | 0.012 | 0.021 | 0.04 | 0.061 | 0.052 | 0.032 |
Total Non-Current Assets
| 4.901 | 5.026 | 3.861 | 1.618 | 2.063 | 0.825 | 0.151 |
Total Assets
| 31.74 | 25.03 | 27.465 | 26.319 | 17.072 | 28.327 | 13.443 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 1.848 | 1.766 | 1.774 | 2.344 | 0.575 | 1.421 | 0.539 |
Short Term Debt
| 5.433 | 1.033 | 1.418 | 0.28 | 0.133 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | -0.133 | 0 | 0 |
Other Current Liabilities
| 8.96 | 3.662 | 1.366 | 1.17 | 1.388 | 0.603 | 0.254 |
Total Current Liabilities
| 16.241 | 6.461 | 4.558 | 3.794 | 1.963 | 2.024 | 0.793 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0.022 | 5.491 | 5.277 | 6.862 | 4.559 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0.52 |
Total Non-Current Liabilities
| 0.022 | 5.491 | 5.277 | 6.862 | 4.559 | 1.421 | 0.52 |
Total Liabilities
| 16.263 | 11.952 | 9.835 | 10.656 | 6.522 | 2.024 | 1.313 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 19.004 |
Common Stock
| 0.026 | 0.025 | 0.025 | 0.024 | 0.018 | 0.018 | 0.006 |
Retained Earnings
| -104.07 | -103.134 | -94.113 | -92.158 | -64.188 | -45.868 | -8.639 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -0 | -19.004 |
Other Total Stockholders Equity
| 119.521 | 116.187 | 111.718 | 107.797 | 74.72 | 72.153 | 20.763 |
Total Shareholders Equity
| 15.477 | 13.078 | 17.63 | 15.663 | 10.55 | 26.303 | 12.13 |
Total Equity
| 15.477 | 13.078 | 17.63 | 15.663 | 10.55 | 26.303 | 12.13 |
Total Liabilities & Shareholders Equity
| 31.74 | 25.03 | 27.465 | 26.319 | 17.072 | 28.327 | 13.443 |